Detalhe da pesquisa
1.
The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling.
Proc Natl Acad Sci U S A
; 121(14): e2315509121, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547055
2.
Inflammatory and immune effects on tumor progression.
Trends Immunol
; 43(2): 93-95, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953686
3.
The cholesterol pathway: impact on immunity and cancer.
Trends Immunol
; 43(1): 78-92, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34942082
4.
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression.
Gastroenterology
; 161(5): 1584-1600, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245764
5.
A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer.
J Pharmacol Exp Ther
; 370(3): 894-901, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30683666
6.
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors.
Cancer Immunol Immunother
; 67(3): 445-457, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29204701
7.
MUC1: a novel metabolic master regulator.
Biochim Biophys Acta
; 1845(2): 126-35, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24418575
8.
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
Proc Natl Acad Sci U S A
; 109(34): 13787-92, 2012 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22869720
9.
Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancer.
Biochemistry
; 53(8): 1360-72, 2014 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24512202
10.
Measurement of Metabolic Alteration in Immune Cells Under Hypoxia.
Methods Mol Biol
; 2755: 201-212, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319580
11.
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation.
bioRxiv
; 2024 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066260
12.
Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells.
Cancer Discov
; 14(1): 176-193, 2024 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931287
13.
Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis.
Nat Cell Biol
; 26(4): 613-627, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429478
14.
LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis.
Cancer Res
; 83(11): 1759-1761, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37264829
15.
CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis.
Oncogene
; 41(7): 971-982, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35001076
16.
Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma.
Cancers (Basel)
; 13(9)2021 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34066839
17.
IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer.
Mol Cancer Ther
; 20(12): 2457-2468, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625505
18.
Metabolic Subtyping for Novel Personalized Therapies Against Pancreatic Cancer.
Clin Cancer Res
; 26(1): 6-8, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628144
19.
Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.
Curr Protoc Pharmacol
; 91(1): e80, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33264501
20.
Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal.
Biochim Biophys Acta Rev Cancer
; 1874(1): 188387, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32579889